Zenith Capital (Zenith Capital) COGS-to-Revenue : 0.00 (As of . 20)

View and export this data going back to 2020. Start your Free Trial

What is Zenith Capital COGS-to-Revenue?

Zenith Capital's Cost of Goods Sold for the three months ended in . 20 was $0.00 Mil. Its Revenue for the three months ended in . 20 was $0.00 Mil.

Zenith Capital's COGS to Revenue for the three months ended in . 20 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Zenith Capital's Gross Margin % for the three months ended in . 20 was N/A%.

Zenith Capital COGS-to-Revenue Historical Data

The historical data trend for Zenith Capital's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zenith Capital COGS-to-Revenue Chart

Zenith Capital Annual Data

Trend

COGS-to-Revenue

Zenith Capital Quarterly Data

COGS-to-Revenue

Zenith Capital COGS-to-Revenue Calculation

Zenith Capital's COGS to Revenue for the fiscal year that ended in . 20 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=		/
	=

Zenith Capital's COGS to Revenue for the quarter that ended in . 20 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=		/
	=

Zenith Capital (OTCPK:ZHCLF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Zenith Capital's Gross Margin % for the three months ended in . 20 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	/
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Zenith Capital COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Zenith Capital's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Zenith Capital (Zenith Capital) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zenith Capital Corp (OTCPK:ZHCLF) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

300, 4820 RIchard Road SW, Calgary, AB, CAN, T3E 6L1

Website

Zenith Capital Corp is a biotechnology investment company. The company operates through its wholly-owned subsidiary Zenith Epigenetics Ltd. It is a clinical-stage biotechnology company focused on discovering and developing novel therapeutics. The company is developing various novel combinations of BET inhibitors with other targeted agents. Its lead compound, ZEN-3694, is in clinical development for metastatic Castration Resistant Prostate Cancer (mCRPC) in collaboration with Astellas and Newsoara and in metastatic triple-negative breast cancer.

Zenith Capital (Zenith Capital) Headlines

No Headlines